Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2020. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3969939011 | Eptinezumab (substance) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3969940013 | Eptinezumab | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Eptinezumab (substance) | Is a | Monoclonal antibody | true | Inferred relationship | Some | ||
| Eptinezumab (substance) | Has disposition (attribute) | Calcitonin gene-related peptide receptor antagonist (disposition) | true | Inferred relationship | Some | ||
| Eptinezumab (substance) | Is a | Substance with calcitonin gene-related peptide receptor antagonist mechanism of action (substance) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Eptinezumab only product in parenteral dose form | Has active ingredient | True | Eptinezumab (substance) | Inferred relationship | Some | 1 |
| Eptinezumab-containing product | Has active ingredient | True | Eptinezumab (substance) | Inferred relationship | Some | 1 |
| Product containing only eptinezumab (medicinal product) | Has active ingredient | True | Eptinezumab (substance) | Inferred relationship | Some | 1 |
| Product containing eptinezumab in parenteral dose form (medicinal product form) | Has active ingredient | True | Eptinezumab (substance) | Inferred relationship | Some | 1 |
Reference Sets
Belgian subset for AllergyIntolerance, causative agent, drug
Description inactivation indicator reference set
FHIR